Echo KB
← Section III · Chamber Size and Function
III.A

Coronary Artery Disease, Stress Echocardiography

16 cards

Notes

Stress echo - indications

  • Diagnosis of obstructive CAD in patients with intermediate pre-test probability.
  • Risk stratification post-MI.
  • Preoperative cardiac risk assessment for non-cardiac surgery.
  • Assessment of viability (dobutamine).
  • Functional assessment of valve disease (low-flow low-gradient AS, exercise MR).
  • Symptom-limited pulmonary artery pressure response in dyspnea of unclear origin.

Modalities

  • Exercise (treadmill or bicycle): more physiologic; higher rate-pressure product; workload quantifiable.
  • Pharmacologic (dobutamine or vasodilator): for patients unable to exercise; also for viability.
  • Vasodilator (adenosine, dipyridamole, regadenoson): coronary vasodilator; heterogeneity of flow reveals ischemia. More commonly paired with nuclear or perfusion echo.

Ischemic response

  • New or worsening regional wall-motion abnormalities = positive study.
  • Reduced or absent wall thickening (< 50 % thickening or < 5 mm excursion) in a coronary distribution.
  • Timing: earlier onset with more severe / multi-vessel disease.
  • Biphasic response (improvement at low dose, worsening at higher dose) = viable but ischemic myocardium (candidate for revascularization).

Dobutamine protocol

  • Incremental dose 5 → 10 → 20 → 30 → 40 μg/kg/min every 3 min.
  • Add atropine 0.25–1 mg if target HR not reached.
  • Target = 85 % of age-predicted maximum HR (220 − age).
  • Endpoints for termination: reaching target HR, new severe wall motion abnormality, > 2 mm ST depression, hypertension (> 220/120), significant hypotension, symptomatic ventricular arrhythmia, intolerable symptoms.

Dobutamine for viability (low-dose)

  • Low dose (5–10 μg/kg/min).
  • Contractile reserve = improvement of a dysfunctional segment at low dose → viable ("hibernating") myocardium.
  • Sustained improvement without worsening at higher dose = stunning without ischemia.
  • Biphasic response = viable AND ischemic = best surgical target.

Complications post-MI

  • VSD: usually 3–7 days post-MI; systolic murmur, left-to-right shunt, PW shows systolic flow across septum. Anterior MI → apical VSD; inferior MI → basal (posterior septum) VSD.
  • Papillary muscle rupture: usually 2–7 days post-MI; posteromedial > anterolateral (single vs dual blood supply). Acute severe MR + flash pulmonary edema.
  • LV free-wall rupture: 3–7 days; often fatal from tamponade.
  • Pseudoaneurysm: contained rupture; narrow neck (neck-to-body ratio < 0.5) vs true aneurysm (wide neck).
  • True aneurysm: full-thickness LV wall protrusion with dyskinesis in a coronary distribution; wide neck; may harbor thrombus.
  • Dressler's syndrome: 2–8 weeks post-MI; pericarditis with effusion, fever, pleuritis.

Aneurysm vs pseudoaneurysm

FeatureTrue aneurysmPseudoaneurysm
WallThinned but continuous myocardiumPericardium/thrombus (contained rupture)
NeckWide (ratio > 0.5)Narrow (ratio < 0.5)
LocationApex (anterior MI)Inferolateral (posterior wall)
Rupture riskLowHigh (surgical urgency)

LV thrombus after MI

  • Usually apical, occurs in large anterior MI with apical akinesis.
  • Contrast echo improves detection when apex is poorly seen.
  • Anticoagulation for 3–6 months.

Coronary artery visualization

  • LMCA - PSAX at aortic valve level, arising at ~2 o'clock.
  • RCA - arising at ~11 o'clock in PSAX; may see PDA on subcostal.
  • LAD - parasternal short-axis at the base or from a modified view.
  • Anomalies of origin - best seen on TEE (short-axis of the aorta at the AV level) or cardiac CT.

Cards

  • basicIII.A-001
    What defines an ischemic response on stress echocardiography?
    New or worsening regional wall-motion abnormalities in a coronary distribution. Reduced thickening (< 50%) or reduced excursion (< 5 mm) of the segment.
  • basicIII.A-002
    What is a 'biphasic response' on dobutamine stress echo and what does it indicate?
    Improvement in a dysfunctional segment at low dobutamine dose, then worsening at higher doses. Indicates VIABLE AND ISCHEMIC myocardium — the best target for revascularization.
  • basicIII.A-003
    Target heart rate for a diagnostic stress echo?
    ≥ 85% of age-predicted maximum HR (220 − age).
  • basicIII.A-004
    Standard dobutamine infusion protocol for stress echo?
    Incremental dose 5 → 10 → 20 → 30 → 40 μg/kg/min, each stage 3 min. Add atropine (0.25–1 mg) if target HR not reached.
  • basicIII.A-005
    Stop criteria for dobutamine stress echo?
    Achievement of target HR; new severe wall-motion abnormality; > 2 mm ST depression; hypertension > 220/120; symptomatic hypotension; symptomatic ventricular arrhythmia; intolerable symptoms.
  • basicIII.A-006
    Typical timing of ventricular septal rupture after MI, and its location by infarct type?
    3–7 days post-MI. Anterior MI (LAD): apical VSD. Inferior MI (RCA): basal (posterior) VSD.
  • basicIII.A-007
    Post-MI papillary muscle rupture — which one is more common and why?
    Posteromedial > anterolateral. Posteromedial PM has a SINGLE blood supply (PDA territory); anterolateral has DUAL supply (LAD + LCx), so is more resistant to ischemia.
  • basicIII.A-008
    Timing of post-MI free-wall rupture and typical outcome?
    3–7 days post-MI. Usually rapidly fatal from cardiac tamponade unless a contained rupture (pseudoaneurysm) develops.
  • basicIII.A-009
    How do you distinguish a true LV aneurysm from a pseudoaneurysm on echo?
    True: wide neck (neck-to-body ratio > 0.5), thinned continuous myocardium, low rupture risk. Pseudoaneurysm: narrow neck (< 0.5), wall composed of pericardium/thrombus, HIGH rupture risk — surgical urgency.
  • basicIII.A-010
    After a large anterior MI, where does an LV thrombus typically form and how do you improve detection?
    At the LV apex with underlying akinesis/dyskinesis. Contrast echo (LV opacification agent) significantly improves detection when the apex is poorly visualized.
  • basicIII.A-011
    Recommended anticoagulation duration for a post-MI LV thrombus?
    3–6 months of therapeutic anticoagulation (warfarin traditionally; DOACs used off-label in many centers). Reassess with imaging.
  • basicIII.A-012
    How does 'contractile reserve' on low-dose dobutamine identify viable myocardium?
    Improvement of contraction in a dysfunctional segment at low-dose dobutamine indicates 'hibernating' viable myocardium. This predicts functional recovery after revascularization.
  • basicIII.A-013
    Dressler's syndrome — timing and features?
    Post-MI pericarditis at 2–8 weeks. Fever, pleuritic chest pain, pericarditis with pericardial effusion. Autoimmune reaction to myocardial antigens.
  • basicIII.A-014
    In coronary segment mapping, which artery supplies the apex?
    The apex has overlap — most commonly LAD supplies the anterior half of the apex; RCA (in a right-dominant system) or LCx (in a left-dominant) supplies the inferior apex. Apical segments are 'shared crown'.
  • basicIII.A-015
    Which stress-echo modality is best when the primary question is myocardial viability?
    Low-dose dobutamine stress echo. Watch for contractile reserve (improvement in resting dysfunctional segments) — most predictive of functional recovery after revascularization.
  • basicIII.A-016
    When is contrast recommended during stress echocardiography?
    When ≥ 2 of 6 basal or mid LV segments cannot be adequately visualized on baseline imaging.